MARC Record from Library of Congress

LEADER: 05400cam a22004334a 4500
001 2008019983
003 DLC
005 20090717104823.0
008 080502s2009 dcuabf b 001 0 eng
010 $a 2008019983
015 $aGBA929047$2bnb
016 7 $a101472901$2DNLM
016 7 $a014933230$2Uk
020 $a9781555814250
020 $a1555814255
035 $a(OCoLC)ocn227268794
040 $aDNLM/DLC$cDLC$dNLM$dBTCTA$dYDXCP$dC#P$dCOU$dCDX$dUKM$dDLC
042 $apcc
050 00 $aRC114.5$b.C56 2009
060 00 $a2009 E-145
060 10 $aWC 500$bC639 2009
082 00 $a616.9/1$222
245 00 $aClinical virology /$ceditors, Douglas D. Richman, Richard J. Whitley, Frederick G. Hayden.
250 $a3rd ed.
260 $aWashington, DC :$bASM Press,$cc2009.
300 $axvi, 1375 p., [24] p. of plates :$bill. (some col.), maps (some col.) ;$c29 cm.
504 $aIncludes bibliographical references and index.
505 00 $tIntroduction /$rDouglas D. Richman, Richard J. Whitley, and Frederick G. Hayden --
505 00 $gSection I: Viral syndromes and general principles --$tRespiratory infections /$rJohn J. Treanor --$tViral central nervous system infections /$rKevin A. Cassady and Richard J. Whitley --$tGastrointestinal syndromes /$rManish Patel and Roger I. Glass --$tViral hepatitis /$rAndrew W. Tai and Jules L. Dienstag --$tInfections in organ transplant recipients /$rJohn A. Zaia --$tViral myocarditis /$rJeffrey A. Towbin --$tViral infections of the skin /$rBrenda L. Bartlett and Stephen K. Tyring --$tViral hemorrhagic fevers: a comparative appraisal /$rMike Bray and Karl M. Johnson --$tViral disease of the eye /$rGarry Shuttleworth and David Easty --$tAntiretroviral agents /$rMagdalena E. Sobieszczyk, Barbara S. Taylor, and Scott M. Hammer --$tAntiherpesvirus, anti-hepatitis virus, and anti-respiratory virus agents /$rMichael T. Yin ... [et al.] --$tDiagnosis of viral infections /$rGuy Boivin ... [et al.] --$tImmune responses to viruses /$rJonathan W. Yewdell, Theodore C. Pierson, and Jack R. Bennink --$tImmunization against viral diseases /$rJulie E. Martin and Barney S. Graham --$tGene therapy and viruses /$rDonald B. Kohn ... [et al.] --$tChronic fatigue and postinfective fatigue syndromes /$rAndrew R. Lloyd, Ian Hickie, and Denis Wakefield --
505 00 $gSection II: The agents --$gPart A: DNA viruses --$tPoxviruses /$rR. Mark Buller and Frank Fenner --$tHerpes simplex viruses /$rRichard J. Whitley and Bernard Roizman --$tCercopithecine herpesvirus 1 (B virus) /$rRichard J. Whitley --$tVaricella-zoster virus /$rAnne A. Gershon and Saul J. Silverstein --$tCytomegalovirus /$rPaul David Griffiths, Vincent Clive Emery, and Richard Milne --$tHuman herpesvirus 6 and human herpesvirus 7 /$rKoichi Yamanishi and Yasuko Mori --$tEpstein-Barr virus /$rKatherine Luzuriaga and John L. Sullivan --$tKaposi's sarcoma-associated herpesvirus /$rPatrick S. Moore and Yuan Chang --$tAdenoviruses /$rOlli Ruuskanen ... [et al.] --$tPolyomaviruses /$rJohn E. Greenlee and Frank J. O'Neill --$tPapillomavirus /$rWilliam Bonnez --$tHuman Parvoviruses /$rLarry J. Anderson and Dean D. Erdman --$tTT virus /$rPeter Simmonds --$tHepatitis B virus /$rAlexander J. V. Thompson, Sally J. Bell, and Stephen A. Locarnini --$gPart B: RNA viruses --$tHuman lymphotropic viruses: HTLV-1 and HTLV-2 /$rWilliam A. Blattner and Manhattan E. Charurat --$tHuman immunodeficiency virus /$rJohn C. Guatelli ... [et al.] --$tColorado tick fever virus and other arthropod-borne Reoviridae /$rSteven Yukl and Joseph K. Wong --$tRotaviruses /$rManuel A. Franco and Harry B. Greenberg --$tRespiratory syncytial virus, human metapneumovirus, and parainfluenza viruses /$rJohn V. Williams, Pedro A. Piedra, and Janet A. Englund --$tMeasles virus /$rWilliam J. Moss and Diane E. Griffin --$tMumps virus /$rJohn W. Gnann, Jr. --$tZoonotic paramyxoviruses /$rPaul A. Rota, Thomas G. Ksiazek, and William J. Bellini --$tRhabdoviruses /$rThomas P. Bleck and Charles E. Rupprecht --$tFiloviruses /$rMike Bray --$tInfluenza virus /$rFrederick G. Hayden and Peter Palese --$tBunyaviridae: bunyaviruses, phleboviruses, nairoviruses, and hantaviruses /$rGregory J. Mertz --$tArenaviruses /$rC. J. Peters --$tEnteroviruses /$rJosé R. Romero --$tRhinovirus /$rRonald B. Turner and Wai-Ming Lee --$tHepatitis A virus /$rPhilip R. Spradling, Annette Martin, and Stephen M. Feinstone --$tHuman caliciviruses /$rRobert L. Atmar and Mary K. Estes --$tHepatitis E virus /$rDavid A. Anderson and Iswar L. Shrestha --$tAstrovirus /$rErnesto Méndez and Carlos F. Arias --$tCoronaviruses /$rKenneth McIntosh and J. S. M. Peiris --$tArthropod-borne flaviviruses /$rLyle R. Petersen and Alan D. T. Barrett --$tHepatitis C virus /$rYaron Rotman and T. Jake Liang --$tAlphaviruses /$rDavid W. Smith, John S. Mackenzie, and Scott C. Weaver --$tRubella virus /$rDavid W. Kimberlin --$gPart C: Subviral agents --$tHepatitis D virus /$rAntonina Smedile, Alessia Ciancio, and Mario Rizzetto --$tTransmissible spongiform encephalopathies /$rAdriano Aguzzi.
650 0 $aVirus diseases.
650 0 $aDiagnostic virology.
650 12 $aVirus Diseases$xdiagnosis.
650 12 $aVirus Diseases$xtherapy.
650 22 $aAntiviral Agents$xtherapeutic use.
650 22 $aViruses$xpathogenicity.
700 1 $aRichman, Douglas D.
700 1 $aWhitley, Richard J.
700 1 $aHayden, Frederick G.